Soleytherapeutics
soleytherapeutics.com
Medical AI
Drug Discovery
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$20M
1 round on record
Latest round
$20M
Venture round · Oct 2020 · 6 yr ago
Backers
1
Breyer Capital
The money's age
Long since its last round
72 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 15, 2020
Raised a round Venture round $20M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2020 | $20M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Soley Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ken AlwynExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Breyer Capital Overview
Soley Therapeutics' proprietary cell stress-sensing platform uncovers first-in-class medicines for complex diseases.
People
Ken Alwyn
Executive Officer, Director
Kurosh Ameri
Director
Yerem Yeghiazarians
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
Financials
Total raised
$20M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2020 | $20M | Details |